Renaissance Technologies’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,012
Closed -$129K 4070
2024
Q1
$129K Buy
15,012
+10,110
+206% +$86.9K ﹤0.01% 3324
2023
Q4
$17K Sell
4,902
-1,825
-27% -$6.33K ﹤0.01% 3602
2023
Q3
$24K Sell
6,727
-447
-6% -$1.6K ﹤0.01% 3507
2023
Q2
$42K Sell
7,174
-1,256
-15% -$7.35K ﹤0.01% 3648
2023
Q1
$319K Buy
8,430
+1,678
+25% +$63.5K ﹤0.01% 3088
2022
Q4
$201K Buy
6,752
+3,357
+99% +$99.9K ﹤0.01% 3419
2022
Q3
$113K Buy
3,395
+765
+29% +$25.5K ﹤0.01% 3554
2022
Q2
$105K Buy
2,630
+1,170
+80% +$46.7K ﹤0.01% 3839
2022
Q1
$77K Sell
1,460
-9,090
-86% -$479K ﹤0.01% 3837
2021
Q4
$584K Sell
10,550
-4,799
-31% -$266K ﹤0.01% 3002
2021
Q3
$1.19M Buy
15,349
+6,672
+77% +$516K ﹤0.01% 2453
2021
Q2
$1.13M Sell
8,677
-3,353
-28% -$435K ﹤0.01% 2614
2021
Q1
$1.98M Buy
12,030
+3,575
+42% +$588K ﹤0.01% 2234
2020
Q4
$1.98M Buy
8,455
+4,380
+107% +$1.02M ﹤0.01% 2119
2020
Q3
$421K Sell
4,075
-9,795
-71% -$1.01M ﹤0.01% 2879
2020
Q2
$544K Buy
13,870
+2,284
+20% +$89.6K ﹤0.01% 2845
2020
Q1
$394K Buy
11,586
+4,010
+53% +$136K ﹤0.01% 2873
2019
Q4
$355K Buy
7,576
+1,137
+18% +$53.3K ﹤0.01% 3021
2019
Q3
$576K Buy
6,439
+393
+7% +$35.2K ﹤0.01% 2820
2019
Q2
$822K Buy
6,046
+899
+17% +$122K ﹤0.01% 2784
2019
Q1
$1.41M Buy
5,147
+942
+22% +$258K ﹤0.01% 2505
2018
Q4
$530K Buy
4,205
+164
+4% +$20.7K ﹤0.01% 2849
2018
Q3
$1.66M Buy
4,041
+441
+12% +$181K ﹤0.01% 2370
2018
Q2
$1.94M Buy
3,600
+1,042
+41% +$563K ﹤0.01% 2273
2018
Q1
$1.18M Buy
2,558
+1,234
+93% +$568K ﹤0.01% 2592
2017
Q4
$887K Buy
1,324
+559
+73% +$374K ﹤0.01% 2711
2017
Q3
$482K Buy
765
+212
+38% +$134K ﹤0.01% 2800
2017
Q2
$265K Buy
553
+237
+75% +$114K ﹤0.01% 2934
2017
Q1
$237K Buy
316
+114
+56% +$85.5K ﹤0.01% 2967
2016
Q4
$197K Buy
202
+130
+181% +$127K ﹤0.01% 3008
2016
Q3
$95K Buy
+72
New +$95K ﹤0.01% 3185